Brief: Lombard Medical receives FDA approval for Aorfix(TM)plus endovascular stent graft
Feb 5 (Reuters) - Lombard Medical Inc EVAR.O : * Receives FDA approval for Aorfix(TM)plus endovascular stent graft expanding its addressable market * Will begin rolling out this expanded range in the second quarter of 2015 with the launch of a 34mm aorfixplus stent graft in the U.S. * Source text for Eikon ID:nGNXVCRRUa * Further company coverage EVAR.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Lombard Medical
See all newsBrief: Lombard Medical Reports First Half and Third Quarter 2017 Financial Results
Brief: Lombard Medical announces completion of restructuring, implementation of strategic plan
Brief: Lombard Medical names Kurt Lemvigh CEO
Brief: Lombard Medical Q4 global revenue $2.4 million, FY 2016 revenue $12.2 mln
Brief: Lombard Medical CEO Simon Hubbert steps down